Kufshina Syrup is a multi-symptom relief formulation containing Phenylephrine (5mg/5ml), Chlorpheniramine Maleate (2mg), and Dextromethorphan Hydrobromide (10mg) per 5ml dose. Phenylephrine acts as a selective alpha-1 adrenergic receptor agonist, providing effective nasal decongestion by constricting dilated blood vessels in the nasal mucosa, thereby reducing swelling and improving airflow. Chlorpheniramine Maleate, a first-generation antihistamine, alleviates allergic symptoms such as sneezing, runny nose, and watery eyes by blocking H1 histamine receptors. Dextromethorphan Hydrobromide serves as a centrally acting antitussive agent that suppresses the cough reflex by acting on the medullary cough center without causing significant respiratory depression. Kufshina Syrup is indicated for symptomatic relief of upper respiratory tract infections, including common cold, allergic rhinitis, and cough associated with bronchitis. It is suitable for adults and children above the recommended age, with dosing adjusted accordingly. Caution is advised in patients with hypertension, glaucoma, or those taking monoamine oxidase inhibitors. Common side effects may include drowsiness, dry mouth, and dizziness. Consultation with a healthcare professional is recommended prior to use to ensure safety and appropriateness of therapy.